Functional assessment improves discrimination of clinical and biomarker-defined Alzheimers disease
In a contemporary, diverse cohort, most established dementia risk algorithms had limited power in discriminating amyloid positivity, pTau-217 positivity, and current cognitive status despite acceptable calibration.